Literature DB >> 25856764

Predictors of successful closure of patent ductus arteriosus with indomethacin.

M F Ahamed1, P Verma2, S Lee3, M Vega1, D Wang4, M Kim4, M Fuloria1.   

Abstract

OBJECTIVE: To determine whether platelet counts can predict the likelihood of successful closure of patent ductus arteriosus (PDA) with indomethacin. STUDY
DESIGN: This was a retrospective cohort study of infants <32 weeks' gestational age (GA) and birth weight <1500 g with PDA. Clinical characteristics between infants who achieved ductal closure with indomethacin and those who failed were compared. Multivariable logistic regression was used to identify predictors of successful ductal closure.
RESULTS: In infants with hemodynamically significant PDA, older GA (odds ratio=1.54; 95% confidence interval: 1.12 to 2.13), male gender (odds ratio=3.02; 95% confidence interval: 1.08 to 8.49) and higher platelet count (odds ratio=1.5; 95% confidence interval: 1.04 to 2.17) prior to indomethacin treatment were associated with successful ductal closure with indomethacin.
CONCLUSION: Older GA, male gender and higher platelet count at time of treatment of hemodynamically significant PDA are predictors of successful ductal closure with indomethacin.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25856764     DOI: 10.1038/jp.2015.33

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  25 in total

1.  Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less.

Authors:  Josh Koch; Gaynelle Hensley; Lonnie Roy; Shannon Brown; Claudio Ramaciotti; Charles R Rosenfeld
Journal:  Pediatrics       Date:  2006-04       Impact factor: 7.124

Review 2.  Patent ductus arteriosus of the preterm infant.

Authors:  Shannon E G Hamrick; Georg Hansmann
Journal:  Pediatrics       Date:  2010-04-26       Impact factor: 7.124

3.  Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.

Authors:  Nahid Waleh; Ryan Hodnick; Nami Jhaveri; Suzanne McConaghy; John Dagle; Steven Seidner; Donald McCurnin; Jeffrey C Murray; Robin Ohls; Ronald I Clyman
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

4.  A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.

Authors:  B Van Overmeire; K Smets; D Lecoutere; H Van de Broek; J Weyler; K Degroote; J P Langhendries
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

5.  Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation.

Authors:  Nahid Waleh; Steven Seidner; Donald McCurnin; Luis Giavedoni; Vida Hodara; Susan Goelz; Bao Mei Liu; Christine Roman; Ronald I Clyman
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

6.  Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.

Authors:  B Van Overmeire; H Van de Broek; P Van Laer; J Weyler; P Vanhaesebrouck
Journal:  J Pediatr       Date:  2001-02       Impact factor: 4.406

7.  Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.

Authors:  Kazuo Itabashi; Tsutomu Ohno; Hiroshi Nishida
Journal:  J Pediatr       Date:  2003-08       Impact factor: 4.406

8.  Failure of ductus arteriosus closure is associated with increased mortality in preterm infants.

Authors:  Shahab Noori; Michael McCoy; Philippe Friedlich; Brianna Bright; Venugopal Gottipati; Istvan Seri; Kris Sekar
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

9.  Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants.

Authors:  B E Stephens; R A Gargus; R V Walden; M Mance; J Nye; L McKinley; R Tucker; B R Vohr
Journal:  J Perinatol       Date:  2007-11-29       Impact factor: 2.521

10.  Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.

Authors:  Jian-Xiong Chen; Patrick W O'Mara; Stanley D Poole; Naoko Brown; Noah J Ehinger; James C Slaughter; Bibhash C Paria; Judy L Aschner; Jeff Reese
Journal:  Pediatr Res       Date:  2012-08       Impact factor: 3.756

View more
  9 in total

1.  CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus.

Authors:  Sydney R Rooney; Elaine L Shelton; Ida Aka; Christian M Shaffer; Ronald I Clyman; John M Dagle; Kelli Ryckman; Tamorah R Lewis; Jeff Reese; Sara L Van Driest; Prince J Kannankeril
Journal:  Pharmacogenomics       Date:  2019-08       Impact factor: 2.533

2.  Intravenous paracetamol for PDA closure in the preterm: a single-center experience.

Authors:  Enrico Valerio; Marta Rossella Valente; Sabrina Salvadori; Anna Chiara Frigo; Eugenio Baraldi; Paola Lago
Journal:  Eur J Pediatr       Date:  2016-05-05       Impact factor: 3.183

3.  Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.

Authors:  Nansi S Boghossian; Barbara T Do; Edward F Bell; John M Dagle; Jane E Brumbaugh; Barbara J Stoll; Betty R Vohr; Abhik Das; Seetha Shankaran; Pablo J Sanchez; Myra H Wyckoff; M Bethany Ball
Journal:  Early Hum Dev       Date:  2017-07-08       Impact factor: 2.079

Review 4.  Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.

Authors:  Yang Hu; Hongfang Jin; Yi Jiang; Junbao Du
Journal:  Pediatr Cardiol       Date:  2018-02-21       Impact factor: 1.655

5.  Association between Platelet Counts before and during Pharmacological Therapy for Patent Ductus Arteriosus and Treatment Failure in Preterm Infants.

Authors:  Hannes Sallmon; Sven C Weber; Juliane Dirks; Tamara Schiffer; Tamara Klippstein; Anja Stein; Ursula Felderhoff-Müser; Boris Metze; Georg Hansmann; Christoph Bührer; Malte Cremer; Petra Koehne
Journal:  Front Pediatr       Date:  2018-03-07       Impact factor: 3.418

6.  Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus.

Authors:  Janardhan Mydam; Alok Rastogi; Zahra J Naheed
Journal:  Ital J Pediatr       Date:  2019-08-22       Impact factor: 2.638

Review 7.  Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants.

Authors:  Hannes Sallmon; Natalie Timme; Begüm Atasay; Ömer Erdeve; Georg Hansmann; Yogen Singh; Sven C Weber; Elaine L Shelton
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.418

Review 8.  Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Moreyba Borges-Lujan; Gema E Gonzalez-Luis; Tom Roosen; Maurice J Huizing; Eduardo Villamor
Journal:  J Pers Med       Date:  2022-07-14

9.  Predictors of successful patent ductus arteriosus closure with acetaminophen in preterm infants.

Authors:  Ruben Vaidya; Alexander Knee; Yvonne Paris; Rachana Singh
Journal:  J Perinatol       Date:  2020-09-02       Impact factor: 2.521

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.